Work

Abstract 4373693: Support duration as a prognostic indicator in temporary MCS: divergent outcomes based on the 14-day FDA approved duration

Year: 2025
Type: conference-abstract
Source: Circulation
Language: English
Open Access status: closed
OpenAlex ID: W4415792075
Cites:
Cited by:
Related to: